Alembic Pharma bags USFDA nod for anti-epileptic drug Ruchika Sharma20 Dec 2024 4:00 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that it has received Final Approval from the US Food & Drug Administration (USFDA)...
Maternal deaths at Ballary District Hospital: Karnataka Drug Controller suspended for negligence Ruchika Sharma2 Dec 2024 5:40 PM ISTBengaluru: Siddaramaiah, the Karnataka Chief Minister has announced the suspension of Umesh, the state Drug Controller, for negligence in...
Sanofi, Regeneron get USFDA nod for Dupixent for COPD Ruchika Sharma29 Sept 2024 12:30 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment...
Torrent Pharma gets one USFDA observation for Pithampur facility Ruchika Sharma19 Sept 2024 5:30 PM ISTAhmedabad: Torrent Pharma has announced that the United States Food & Drug Administration (USFDA) has issued one observation at the end...
DoP is implementing PLI Scheme for Pharma with total financial outlay of Rs 15,000 crore: MoS for Chemicals and Fertilizers Ruchika Sharma3 Aug 2024 11:30 AM ISTNew Delhi: The Department of Pharmaceuticals is implementing the Production Linked Incentive (PLI) Scheme for Pharmaceuticals with a total...
USFDA nod to Johnson and Johnson EDURANT PED for certain pediatric patients living with HIV-1 Ruchika Sharma20 March 2024 12:30 PM ISTTitusville: Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved EDURANT PED (rilpivirine) for the...
Biocon Biologics secures US market entry date for Bmab 1200, a Proposed Biosimilar to Stelara Ruchika Sharma1 March 2024 3:30 PM ISTStelara (Ustekinumab) is a monoclonal antibody medication that prevents abnormal regulation of interleukin IL-12/23 associated immune diseases and has...
Roche Pharma unveils multiple sclerosis treatment drug Ocrevus in India Ruchika Sharma29 Feb 2024 5:00 PM ISTNew Delhi: Roche Pharma India has launched a drug for the treatment of Multiple Sclerosis (MS), expanding its neurology portfolio to cater...
